Evidence map›Paper›PMID 35797036›Full record

ArticleJAMA ophthalmology2022

External Validation of a Retinopathy of Prematurity Screening Model Using Artificial Intelligence in 3 Low- and Middle-Income Populations.

Aaron S Coyner, Minn A Oh, Parag K Shah, Praveer Singh, Susan Ostmo, Nita G Valikodath, Emily Cole, Tala Al-Khaled, Sanyam Bajimaya, Sagun K C and 10 more

Open access · greenAbstract read
In one paragraph

Article in JAMA ophthalmology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 4 pooled it
6.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 4 syntheses or guidelines pooled it, 46 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Review
  8. Article
  9. Observational
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors at 10 institutions in 4 countries.

Aaron S CoynerCasey Eye Institute, Oregon Health & Science University, Portland.
Minn A OhCasey Eye Institute, Oregon Health & Science University, Portland.
Parag K ShahPediatric Retina and Ocular Oncology Division, Aravind Eye Hospital, Coimbatore, India.
Praveer SinghMassachusetts General Hospital and Brigham and Women's Hospital Center for Clinical Data Science, Boston, Massachusetts.
Susan OstmoCasey Eye Institute, Oregon Health & Science University, Portland.
Nita G ValikodathIllinois Eye and Ear Infirmary, University of Illinois at Chicago, Chicago.
Emily ColeIllinois Eye and Ear Infirmary, University of Illinois at Chicago, Chicago.
Tala Al-KhaledIllinois Eye and Ear Infirmary, University of Illinois at Chicago, Chicago.
Sanyam BajimayaTilganga Institute of Ophthalmology, Kathmandu, Nepal.
Sagun K CHelen Keller International, Kathmandu, Nepal.
Tsengelmaa ChuluunbatNational Center for Maternal and Child Health, Ulaanbaatar, Mongolia.
Bayalag MunkhuuNational Center for Maternal and Child Health, Ulaanbaatar, Mongolia.
Prema SubramanianPediatric Retina and Ocular Oncology Division, Aravind Eye Hospital, Coimbatore, India.
Narendran VenkatapathyPediatric Retina and Ocular Oncology Division, Aravind Eye Hospital, Coimbatore, India.
Karyn E JonasIllinois Eye and Ear Infirmary, University of Illinois at Chicago, Chicago.
Joelle A HallakIllinois Eye and Ear Infirmary, University of Illinois at Chicago, Chicago.
R V Paul ChanIllinois Eye and Ear Infirmary, University of Illinois at Chicago, Chicago.
Michael F ChiangNational Eye Institute, National Institutes of Health, Bethesda, Maryland.
Jayashree Kalpathy-CramerMassachusetts General Hospital and Brigham and Women's Hospital Center for Clinical Data Science, Boston, Massachusetts.
J Peter CampbellCasey Eye Institute, Oregon Health & Science University, Portland.
Oregon Health & Science University · USAravind Eye Hospital · INNew York Eye and Ear Infirmary · USUniversity of Illinois Chicago · USNational Center for Communicable Diseases · MNHarvard University · USHelen Keller International Nepal · NPMassachusetts General Hospital · USNational Eye Institute · USTilganga Institute of Ophthalmology · NP

Funding

Translational Core for Therapeutic and Diagnostic DevelopmentP30EY001792 · NEI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI AAKALU, VINAY · 1985 to 2025
$14.8M
Clinical and Genetic Analysis of Retinopathy of PrematurityR01EY019474 · NEI · OREGON HEALTH & SCIENCE UNIVERSITY · PI CAMPBELL, JOHN PETER · 2010 to 2020
$7.0M
Artificial Intelligence Assisted Panoramic Optical Coherence Tomography Angiography for Retinopathy of PrematurityR01HD107494 · NICHD · OREGON HEALTH & SCIENCE UNIVERSITY · PI John Peter Campbell, Yifan Jian · 2021 to 2026
$2.4M
Clinical and genetic analysis of retinopathy of prematurityR01HD107493 · NICHD · OREGON HEALTH & SCIENCE UNIVERSITY · PI CAMPBELL, JOHN PETER · 2021 to 2023
$1.8M
Artificial intelligence assisted panoramic Optical Coherence Tomography Angiography for Retinopathy of PrematurityR01EY031331 · NEI · OREGON HEALTH & SCIENCE UNIVERSITY · PI CAMPBELL, JOHN PETER, JIAN, YIFAN · 2020 to 2020
$342k
NEI NIH HHS P30 EY001792NEI NIH HHS R01 EY019474NICHD NIH HHS R01 HD107493
6 · The paper itself

Abstract

Importance: Retinopathy of prematurity (ROP) is a leading cause of preventable blindness that disproportionately affects children born in low- and middle-income countries (LMICs). In-person and telemedical screening examinations can reduce this risk but are challenging to implement in LMICs owing to the multitude of at-risk infants and lack of trained ophthalmologists. Objective: To implement an ROP risk model using retinal images from a single baseline examination to identify infants who will develop treatment-requiring (TR)-ROP in LMIC telemedicine programs. Design, Setting, and Participants: In this diagnostic study conducted from February 1, 2019, to June 30, 2021, retinal fundus images were collected from infants as part of an Indian ROP telemedicine screening program. An artificial intelligence (AI)-derived vascular severity score (VSS) was obtained from images from the first examination after 30 weeks' postmenstrual age. Using 5-fold cross-validation, logistic regression models were trained on 2 variables (gestational age and VSS) for prediction of TR-ROP. The model was externally validated on test data sets from India, Nepal, and Mongolia. Data were analyzed from October 20, 2021, to April 20, 2022. Main Outcomes and Measures: Primary outcome measures included sensitivity, specificity, positive predictive value, and negative predictive value for predictions of future occurrences of TR-ROP; the number of weeks before clinical diagnosis when a prediction was made; and the potential reduction in number of examinations required. Results: A total of 3760 infants (median [IQR] postmenstrual age, 37 [5] weeks; 1950 male infants [51.9%]) were included in the study. The diagnostic model had a sensitivity and specificity, respectively, for each of the data sets as follows: India, 100.0% (95% CI, 87.2%-100.0%) and 63.3% (95% CI, 59.7%-66.8%); Nepal, 100.0% (95% CI, 54.1%-100.0%) and 77.8% (95% CI, 72.9%-82.2%); and Mongolia, 100.0% (95% CI, 93.3%-100.0%) and 45.8% (95% CI, 39.7%-52.1%). With the AI model, infants with TR-ROP were identified a median (IQR) of 2.0 (0-11) weeks before TR-ROP diagnosis in India, 0.5 (0-2.0) weeks before TR-ROP diagnosis in Nepal, and 0 (0-5.0) weeks before TR-ROP diagnosis in Mongolia. If low-risk infants were never screened again, the population could be effectively screened with 45.0% (India, 664/1476), 38.4% (Nepal, 151/393), and 51.3% (Mongolia, 266/519) fewer examinations required. Conclusions and Relevance: Results of this diagnostic study suggest that there were 2 advantages to implementation of this risk model: (1) the number of examinations for low-risk infants could be reduced without missing cases of TR-ROP, and (2) high-risk infants could be identified and closely monitored before development of TR-ROP.

Indexed as

Retinopathy of PrematurityAdultArtificial IntelligenceChildGestational AgeHumansInfantInfant, NewbornMaleNeonatal ScreeningRetrospective StudiesRisk FactorsSensitivity and Specificity

Identifiers

PMID35797036
PMCPMC9264225
OpenAlexW4284676071

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.